MARLBOROUGH, Mass.--(BUSINESS WIRE)--EXACT Sciences Corporation (NASDAQ: EXAS) announced today that the European Patent Office (EPO) has upheld a patent owned by the Company pertaining to aspects of its DNA technologies. The decision by the EPO’s Opposition Division was in response to a challenge by a major diagnostics company seeking to invalidate the patent claims.
